Delgocitinib (2) – Anzupgo®

Chronic hand eczema, aged ≥ 12 to < 18 years

Characteristics

Start date 15.11.2026
Resolution 05.05.2027 – active procedure
INN Delgocitinib
Brand name Anzupgo®
Pharm. company LEO Pharma GmbH
G-BA Procedure ID D-1397
Therapeutic area Skin diseases
Reason for procedure New therapeutic indication

Associated procedures

Delgocitinib (2) Anzupgo® LEO Pharma GmbH Skin diseases Chronic hand eczema, aged ≥ 12 to < 18 years n.d. active procedure
Delgocitinib (1) Anzupgo® LEO Pharma GmbH Skin diseases Moderate to severe chronic hand eczema 160,000–200,000 100% additional benefit not proven


<< List of all resolutions